Sfrp2-flox Mouse
一般名
Sfrp2-flox
製品ID
S-CKO-04972
背景情報
C57BL/6JCya
系統ID
CKOCMP-20319-Sfrp2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Sfrp2-flox Mouse(カタログ番号S-CKO-04972)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Sfrp2-flox
系統ID
CKOCMP-20319-Sfrp2-B6J-VA
遺伝子名
製品ID
S-CKO-04972
遺伝子別名
Sdf5
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 3
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000029625
NCBIトランスクリプトID
NM_009144
ターゲット領域
Exon 1
有効領域の大きさ
~3.4 kb
遺伝子研究の概要
Sfrp2, or Secreted frizzled-related protein 2, is a vital molecule in the Wnt signaling pathway. It can act as an antagonist of the canonical Wnt signaling pathway and is involved in regulating multiple biological processes such as organ development and disease processes [7].
In skin, Sfrp2 defines a major fibroblast population with distinct morphology and function compared to other fibroblast populations defined by genes like FMO1. Sfrp2+ fibroblasts are small, elongated, and distributed between collagen bundles, and differential gene expression suggests their role in matrix deposition [1].
In diabetic cardiomyopathy, Sfrp2 is downregulated, and its overexpression can reverse apoptosis and promote mitochondrial function in an AMPK-PGC1-α-dependent manner, while silencing endogenous Sfrp2 promotes glucolipotoxicity-induced mitochondrial dysfunction and apoptosis [2].
In radioimmunotherapy, conditional Sfrp2 knockout in cancer-associated fibroblasts (CAFs) boosts the abscopal effect by rewiring the vascular-immune microenvironment to promote CD8+ T cell recruitment to unirradiated tumors [3].
In aged-related melanoma, aged fibroblasts secrete sFRP2, which drives melanoma metastasis and therapy resistance through a multi-step signaling cascade [4].
In systemic sclerosis skin, SSc dermal myofibroblasts arise from an SFRP2hi/DPP4-expressing progenitor fibroblast population [5].
In idiopathic pulmonary fibrosis, a fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia [6].
In cardiomyogenesis, Sfrp2 promotes the differentiation of multipotent cKit(+) cells into cardiomyocytes in vivo, improving cardiac function in an injury model [8].
In preeclampsia, SFRP2 overexpression in JEG-3 cells reduces cell viability, proliferation, and migration, and increases apoptosis by inhibiting the Wnt/β-catenin pathway [9].
In diabetic wound healing, suppression of SFRP2 delays the wound healing process in diabetic mice, affects macrophage infiltration and functional phenotype transition, and energy metabolism [10].
In conclusion, Sfrp2 plays diverse and crucial roles in various biological processes and disease conditions. Studies using gene knockout or conditional knockout models in mice have revealed its significance in areas such as skin fibroblast function, diabetic cardiomyopathy, cancer therapy response, melanoma metastasis, fibrosis development, cardiomyogenesis, preeclampsia, and diabetic wound healing. These findings enhance our understanding of Sfrp2's biological functions and provide potential therapeutic targets for related diseases.
References:
1. Tabib, Tracy, Morse, Christina, Wang, Ting, Chen, Wei, Lafyatis, Robert. 2017. SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin. In The Journal of investigative dermatology, 138, 802-810. doi:10.1016/j.jid.2017.09.045. https://pubmed.ncbi.nlm.nih.gov/29080679/
2. Ma, Tianyi, Huang, Xiaohui, Zheng, Haoxiao, Hu, Yunzhao, Huang, Yuli. 2021. SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy. In Oxidative medicine and cellular longevity, 2021, 9265016. doi:10.1155/2021/9265016. https://pubmed.ncbi.nlm.nih.gov/34790288/
3. Zhang, Yan-Pei, Guo, Ze-Qin, Cai, Xiao-Ting, Wu, De-Hua, Dong, Zhong-Yi. 2025. PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. In Cancer cell, 43, 856-874.e9. doi:10.1016/j.ccell.2025.02.024. https://pubmed.ncbi.nlm.nih.gov/40086438/
4. Kaur, Amanpreet, Webster, Marie R, Marchbank, Katie, Ribas, Antoni, Weeraratna, Ashani T. 2016. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. In Nature, 532, 250-4. doi:10.1038/nature17392. https://pubmed.ncbi.nlm.nih.gov/27042933/
5. Tabib, Tracy, Huang, Mengqi, Morse, Nina, Domsic, Robyn, Lafyatis, Robert. 2021. Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin. In Nature communications, 12, 4384. doi:10.1038/s41467-021-24607-6. https://pubmed.ncbi.nlm.nih.gov/34282151/
6. Cohen, Max L, Brumwell, Alexis N, Ho, Tsung Che, Chapman, Harold A, Le Saux, Claude Jourdan. 2024. A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis. In The Journal of clinical investigation, 134, . doi:10.1172/JCI174598. https://pubmed.ncbi.nlm.nih.gov/38980870/
7. Wu, Yu, Liu, Xinyue, Zheng, Haoxiao, Huang, Xiaohui, Huang, Yuli. 2020. Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease. In International journal of biological sciences, 16, 730-738. doi:10.7150/ijbs.40923. https://pubmed.ncbi.nlm.nih.gov/32071544/
8. Gomez, José A, Payne, Alan, Pratt, Richard E, Hodgkinson, Conrad P, Dzau, Victor J. . A role for Sfrp2 in cardiomyogenesis in vivo. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2103676118. https://pubmed.ncbi.nlm.nih.gov/34380738/
9. Lan, Ruihong, Yu, Yihong, Song, Jie, Xue, Mengdi, Gong, Humin. 2024. SFRP2 suppresses trophoblast cell migration by inhibiting the Wnt/β‑catenin pathway. In Molecular medicine reports, 29, . doi:10.3892/mmr.2024.13190. https://pubmed.ncbi.nlm.nih.gov/38426532/
10. Yang, Jiaqi, Xiong, Guorui, He, Huijuan, Huang, Haili. 2024. SFRP2 modulates functional phenotype transition and energy metabolism of macrophages during diabetic wound healing. In Frontiers in immunology, 15, 1432402. doi:10.3389/fimmu.2024.1432402. https://pubmed.ncbi.nlm.nih.gov/39464880/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
